Role of the potassium channel KCa3.1 in diabetic nephropathy.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Clinical science

• Publication date

  2014-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1042/CS20140075PMID 24963668
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Drugs for preventing red blood cell dehydration in people with sickle cell disease.

  2016cited by this paper
• High Glucose Induces CCL20 in Proximal Tubular Cells via Activation of the KCa3.1 Channel

  2014cited by this paper
• Inhibition of KCa3.1 suppresses TGF-β1 induced MCP-1 expression in human proximal tubular cells through Smad3, p38 and ERK1/2 signaling pathways.

  2014cited by this paper
• Renal epithelial injury and fibrosis.

  2013cited by this paper
• Advanced glycation end products impair KCa3.1- and KCa2.3-mediated vasodilatation via oxidative stress in rat mesenteric arteries

  2013cited by this paper
• Diabetic kidney disease and immune modulation.

  2013cited by this paper
• Blockade of KCa3.1 Ameliorates Renal Fibrosis Through the TGF-β1/Smad Pathway in Diabetic Mice

  2013cited by this paper
• Purinergic regulation of CFTR and Ca(2+)-activated Cl(-) channels and K(+) channels in human pancreatic duct epithelium.

  2013cited by this paper
• Endothelial Small-Conductance and Intermediate-Conductance KCa Channels: An Update on Their Pharmacology and Usefulness as Cardiovascular Targets

  2013cited by this paper
• KCa3.1 mediates activation of fibroblasts in diabetic renal interstitial fibrosis

  2013cited by this paper
• Origin and function of myofibroblasts in kidney fibrosis

  2013cited by this paper
• Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis

  2013cited by this paper
• Potassium channels: a review of broadening therapeutic possibilities for neurological diseases

  2013cited by this paper
• Mechanisms of diabetic complications.

  2013cited by this paper
• Inflammation and the pathogenesis of diabetic nephropathy.

  2013cited by this paper
• Role of KCa3.1 channels in proliferation and migration of vascular smooth muscle cells by diabetic rat serum.

  2013cited by this paper
• Inflammation in Diabetic Nephropathy

  2012cited by this paper
• The pathogenic role of the renal proximal tubular cell in diabetic nephropathy.

  2012cited by this paper
• Drugs for preventing red blood cell dehydration in people with sickle cell disease.

  2012cited by this paper
• Expression and Role of the Intermediate-Conductance Calcium-Activated Potassium Channel KCa3.1 in Glioblastoma

  2012cited by this paper
• KCa2 and KCa3 Channels in Learning and Memory Processes, and Neurodegeneration

  2012cited by this paper
• Microglial KCa3.1 Channels as a Potential Therapeutic Target for Alzheimer's Disease

  2012cited by this paper
• Role of vascular potassium channels in the regulation of renal hemodynamics.

  2012cited by this paper
• The Inhibition of KCa3.1 Channels Activity Reduces Cell Motility in Glioblastoma Derived Cancer Stem Cells

  2012cited by this paper
• Can we target tubular damage to prevent renal function decline in diabetes?

  2012cited by this paper
• Endocannabinoids and the renal proximal tubule: an emerging role in diabetic nephropathy.

  2012cited by this paper
• Epithelial‐mesenchymal transition in renal fibrosis – evidence for and against

  2011cited by this paper
• Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy?

  2011cited by this paper
• Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases.

  2011cited by this paper
• Globotriaosylceramide leads to K(Ca)3.1 channel dysfunction: a new insight into endothelial dysfunction in Fabry disease.

  2011cited by this paper
• Risk for ESRD in type 1 diabetes remains high despite renoprotection.

  2011cited by this paper
• The proximal tubule in the pathophysiology of the diabetic kidney.

  2011cited by this paper
• Role of T Cells in Type 2 Diabetic Nephropathy

  2011cited by this paper
• Inhibition of the Ca2+-Dependent K+ Channel, KCNN4/KCa3.1, Improves Tissue Protection and Locomotor Recovery after Spinal Cord Injury

  2011cited by this paper
• Intermediate-Conductance Ca2+-Activated K+ Channel, KCa3.1, as a Novel Therapeutic Target for Benign Prostatic Hyperplasia

  2011cited by this paper
• The role of EMT in renal fibrosis

  2011cited by this paper
• The KCa3.1 Blocker TRAM-34 Reduces Infarction and Neurological Deficit in a Rat Model of Ischemia/Reperfusion Stroke

  2011cited by this paper
• Endothelial Factors and Diabetic Nephropathy

  2011cited by this paper
• The lymphocyte potassium channels Kv1.3 and KCa3.1 as targets for immunosuppression

  2011cited by this paper
• Cellular and molecular mechanisms of renal fibrosis

  2011cited by this paper
• NS309 restores EDHF‐type relaxation in mesenteric small arteries from type 2 diabetic ZDF rats

  2010cited by this paper
• Endothelium-derived hyperpolarising factors and associated pathways: a synopsis

  2010cited by this paper
• Mechanisms of tubulointerstitial fibrosis.

  2010cited by this paper
• Calcium-activated potassium channels – a therapeutic target for modulating nitric oxide in cardiovascular disease?

  2010cited by this paper
• CD4+ T cells: a potential player in renal fibrosis.

  2010cited by this paper
• Epithelial and Mesenchymal Cell Biology Pericytes and Perivascular Fibroblasts Are the Primary Source of Collagen-Producing Cells in Obstructive Fibrosis of the Kidney

  2010cited by this paper
• Urinary biomarkers trefoil factor 3 and albumin enable early detection of kidney tubular injury

  2010cited by this paper
• Mucosal potassium efflux mediated via Kcnn4 channels provides the driving force for electrogenic anion secretion in colon.

  2010cited by this paper
• Vascular KCa-channels as therapeutic targets in hypertension and restenosis disease

  2010cited by this paper
• Therapeutic potential of KCa3.1 blockers: recent advances and promising trends

  2010cited by this paper
• Losartan normalizes endothelium-derived hyperpolarizing factor-mediated relaxation by activating Ca2+-activated K+ channels in mesenteric artery from type 2 diabetic GK rat.

  2010cited by this paper
• Review: Endothelial‐myofibroblast transition, a new player in diabetic renal fibrosis

  2010cited by this paper
• Inhibition of the K+ channel KCa3.1 ameliorates T cell–mediated colitis

  2010cited by this paper
• The intermediate-conductance Ca2+ -activated K+ channel (KCa3.1) in vascular disease.

  2009cited by this paper
• Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice.

  2009cited by this paper
• Genetic Deficit of SK3 and IK1 Channels Disrupts the Endothelium-Derived Hyperpolarizing Factor Vasodilator Pathway and Causes Hypertension

  2009cited by this paper
• Endothelial Ca2+‐activated K+ channels in normal and impaired EDHF–dilator responses – relevance to cardiovascular pathologies and drug discovery

  2009cited by this paper
• Senicapoc (ICA-17043): a potential therapy for the prevention and treatment of hemolysis-associated complications in sickle cell anemia.

  2009cited by this paper
• EF hands at the N-lobe of calmodulin are required for both SK channel gating and stable SK–calmodulin interaction

  2009cited by this paper
• Blockade of T-lymphocyte KCa3.1 and Kv1.3 channels as novel immunosuppression strategy to prevent kidney allograft rejection.

  2009cited by this paper
• Inhibition of the KCa3.1 channels by AMP-activated protein kinase in human airway epithelial cells.

  2009cited by this paper
• Senicapoc (ICA-17043): a potential therapy for the prevention and treatment of hemolysis-associated complications in sickle cell anemia

  2009cited by this paper
• Renal fibrosis is attenuated by targeted disruption of KCa3.1 potassium channels

  2009cited by this paper
• Calcium‐activated potassium channels and endothelial dysfunction: therapeutic options?

  2009cited by this paper
• Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia.

  2008cited by this paper
• Local Delivery of the KCa3.1 Blocker, TRAM-34, Prevents Acute Angioplasty-Induced Coronary Smooth Muscle Phenotypic Modulation and Limits Stenosis

  2008cited by this paper
• KCa3.1 potassium channels are critical for cAMP-dependent chloride secretion and cyst growth in autosomal-dominant polycystic kidney disease.

  2008cited by this paper
• KCa3.1: target and marker for cancer, autoimmune disorder and vascular inflammation?

  2008cited by this paper
• Protein histidine phosphatase 1 negatively regulates CD4 T cells by inhibiting the K+ channel KCa3.1

  2008cited by this paper
• Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition.

  2008cited by this paper
• The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans.

  2008cited by this paper
• The role of chemokines and chemokine receptors in diabetic nephropathy.

  2008cited by this paper
• The renal cortical interstitium: morphological and functional aspects

  2008cited by this paper
• Sequential Shrinkage and Swelling Underlie P2X7-Stimulated Lymphocyte Phosphatidylserine Exposure and Death1

  2008cited by this paper
• K+ channel modulators for the treatment of neurological disorders and autoimmune diseases.

  2008cited by this paper
• The expression and function of Ca2+‐sensing receptors in rat mesenteric artery; comparative studies using a model of type II diabetes

  2008cited by this paper
• Formation and function of the myofibroblast during tissue repair.

  2007cited by this paper
• Effects of methyl β‐cyclodextrin on EDHF responses in pig and rat arteries; association between SKCa channels and caveolin‐rich domains

  2007cited by this paper
• Blockage of intermediate-conductance-Ca2+-activated K+ channels inhibits progression of human endometrial cancer

  2007cited by this paper
• High glucose induces macrophage inflammatory protein-3 alpha in renal proximal tubule cells via a transforming growth factor-beta 1 dependent mechanism.

  2007cited by this paper
• Modulators of small- and intermediate-conductance calcium-activated potassium channels and their therapeutic indications.

  2007cited by this paper
• Endothelium-dependent relaxation is resistant to inhibition of nitric oxide synthesis, but sensitive to blockade of calcium-activated potassium channels in essential hypertension

  2007cited by this paper
• Regulation of Endothelial-Dependent Relaxation in Human Systemic Arteries by SKCa and IKCa Channels

  2007cited by this paper
• Histopathology of diabetic nephropathy.

  2007cited by this paper
• The Contribution of Bone Marrow‐Derived Cells to the Development of Renal Interstitial Fibrosis

  2007cited by this paper
• Calcium-activated potassium channel and connexin expression in small mesenteric arteries from eNOS-deficient (eNOS-/-) and eNOS-expressing (eNOS+/+) mice.

  2007cited by this paper
• Dihydropyridines Inhibit Acetylcholine-Induced Hyperpolarization in Cochlear Artery via Blockade of Intermediate-Conductance Calcium-Activated Potassium Channels

  2007cited by this paper
• ROLE OF MACROPHAGES IN COMPLICATIONS OF TYPE 2 DIABETES

  2007cited by this paper
• Small- and intermediate-conductance Ca2+-activated K+ channels directly control agonist-evoked nitric oxide synthesis in human vascular endothelial cells.

  2007cited by this paper
• Expression and Modulation of the Intermediate- Conductance Ca2+-Activated K+ Channel in Glioblastoma GL-15 Cells

  2006cited by this paper
• Leukocyte recruitment and vascular injury in diabetic nephropathy.

  2006cited by this paper
• Impaired Endothelium-Derived Hyperpolarizing Factor–Mediated Dilations and Increased Blood Pressure in Mice Deficient of the Intermediate-Conductance Ca2+-Activated K+ Channel

  2006cited by this paper
• Histidine phosphorylation of the potassium channel KCa3.1 by nucleoside diphosphate kinase B is required for activation of KCa3.1 and CD4 T cells.

  2006cited by this paper
• Distinct K+ conductive pathways are required for Cl- and K+ secretion across distal colonic epithelium.

  2006cited by this paper
• Functional KCa3.1 K+ channels are required for human lung mast cell migration

  2006cited by this paper
• Renal fibroblasts and myofibroblasts in chronic kidney disease.

  2006cited by this paper
• Ca2+-activated K+ channels in human melanoma cells are up-regulated by hypoxia involving hypoxia-inducible factor-1alpha and the von Hippel-Lindau protein.

  2006cited by this paper
• Dose‐Escalation Study of ICA‐17043 in Patients with Sickle Cell Disease

  2006cited by this paper
• Macrophage accumulation in human progressive diabetic nephropathy

  2006cited by this paper
• Ca2+‐activated K+ channels in human melanoma cells are up‐regulated by hypoxia involving hypoxia‐inducible factor‐1α and the von Hippel‐Lindau protein

  2006cited by this paper

• The KCa3.1 K+ Channel and Cardiovascular Disease: An Upstream Target Linking Inflammation, Fibrosis and Electrical Instability

  2026cites this paper
• The key mediator of diabetic kidney disease: Potassium channel dysfunction

  2023cites this paper
• Functional Potassium Channels in Macrophages

  2023cites this paper
• Regulatory role of KCa3.1 in immune cell function and its emerging association with rheumatoid arthritis

  2022cites this paper
• ATP-evoked intracellular Ca2+ transients shape the ionic permeability of human microglia from epileptic temporal cortex

  2021cites this paper
• Crocin Improves Endothelial Mitochondrial Dysfunction via GPx1/ROS/KCa3.1 Signal Axis in Diabetes

  2021cites this paper
• ImKTx96, a peptide blocker of the Kv1.2 ion channel from the venom of the scorpion Isometrus maculates.

  2020cites this paper
• KCa3.1 in Epithelia

  2020cites this paper
• Ion channels and transporters in diabetic kidney disease.

  2019cites this paper
• Conditional KCa3.1-transgene induction in murine skin produces pruritic eczematous dermatitis with severe epidermal hyperplasia and hyperkeratosis

  2019cites this paper
• Translational science in chronic kidney disease.

  2017cites this paper
• KCa3.1 as a novel therapeutic target for diabetic nephropathy

  2017cites this paper
• Endothelial Small- and Intermediate-Conductance K Channels and Endothelium-Dependent Hyperpolarization as Drug Targets in Cardiovascular Disease.

  2016cites this paper
• Immature human dendritic cells enhance their migration through KCa3.1 channel activation.

  2016cites this paper
• Glutamate and GABA signalling components in the human brain and in immune cells

  2016cites this paper
• Mineral Elements in Barley Grass Powder and its Grains for Recombinant Inbred Lines by ICP-AES

  2016cites this paper
• Inhibitory actions by ibandronate sodium, a nitrogen-containing bisphosphonate, on calcium-activated potassium channels in Madin–Darby canine kidney cells

  2015cites this paper
• Lentiviral shRNA against KCa3.1 inhibits allergic response in allergic rhinitis and suppresses mast cell activity via PI3K/AKT signaling pathway

  2015cites this paper